August 21, 2024
Proposed Risk Factor Tool Finds Heart Failure Rates are Higher Among American Indian Adults
Aug. 21, 2024 — The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than…
Read More
Ann Marie Navar, M.D., Ph.D.
August 15, 2024
Researchers Find ApoB Test May be More Accurate Measure of Heart Disease Risk
Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for…
Read More
August 14, 2024
Study: Chronic High Caffeine Consumption May Heighten Cardiovascular Disease Risk
Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of…
Read More
August 09, 2024
Researchers Find Short, Intense Bursts of Exercise More Effective for Stroke Victims Versus Steady, Moderate Exercise
According to research published in Stroke, the peer-reviewed scientific journal of the American Stroke Association, …
Read More
August 08, 2024
Study: Cardiology Trainees May Be Exposed to Unnecessary Radiation Risks
Aug. 8, 2024 — Radiation from X-rays is an occupational hazard for many medical specialists, including cardiologists,…
Read More
The American College of Cardiology has released a workbook on remote patient management (RPM), which aims to guide CV care professionals on definitions, clinical uses, benefits and limitations.
July 31, 2024
American College of Cardiology, ACC, Releases Guide to Remote Patient Management
July 31, 2024 — The American College of Cardiology (ACC) has announced its release of the ACC Remote Patient Management…
Read More
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, reported it has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath
July 31, 2024
BioCardia Submits for FDA Approval of Morph DNA Steerable Introducer Product Family
July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
Research featured in Nature Medicine paves the way for diagnosing more patients with unexplained shortness of breath
July 31, 2024
University Hospitals Researcher Develops New Score System to Better Screen and Treat HFpEF Heart Failure Patients
July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart…
Read More
The Heart Rhythm Society (HRS) is preparing for HRX 2024, to be held September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators.
July 30, 2024
Heart Rhythm Society’s HRX 2024 to Draw Cardiovascular Innovators to Atlanta
July 30, 2024 — The Heart Rhythm Society (HRS) is preparing for HRX 2024, bringing cardiovascular health innovators to…
Read More
This study by Fujita Health University researchers revealed that kidney function, considered in terms of estimated glomerular filtration rate (eGFR), can be used as a predictor for SCD in patients with congestive heart failure.
July 30, 2024
Kidney Dysfunction May Predict Sudden Cardiac Death in Patients with Heart Failure
July 30, 2024 — Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of…
Read More
Magenta Medical, developer of Elevate, the world's smallest heart pump, has closed a $105M financing round led by global healthcare investment firm Novo Holdings, according to a statement issued by the company, led by led by Dr. David Israeli, CEO...
July 29, 2024
Magenta Medical, Developer of World’s Smallest Heart Pump, Closes $105M Financing Round
July 29, 2024 — Magenta Medical, developer of Elevate, the world's smallest heart pump, has closed a $105M financing…
Read More
July 29, 2024
CorVascular’s VasoGuard Earns FDA 510(k) Clearance
July 29, 2024 — CorVascular, a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD…
Read More
R-EDByUS score features variables using only prehospital resuscitation data
July 29, 2024
Rapid and Accurate Prediction Model for Cardiac Arrest Treatment
July 29, 2024 — When it comes to treating cardiac arrest, acting quickly can mean the difference between life and death…
Read More
Edwards anticipates FDA approval of the JenaValve Trilogy Heart Valve System in late 2025
July 29, 2024
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing…
Read More
Danish medtech start-up VentriJect has been invited to the upcoming United Nations General Assembly (UNGA) Digital Health Symposium in New York to demonstrate Seismofit, its portable and fast VO2 max estimation solution.
July 26, 2024
MedTech Startup VentriJect Selected to Demonstrate Siesmofit System to United Nations Digital Health Symposium
July 26, 2024 — VentriJect, a Danish medtech start-up seeking to revolutionize the way cardiorespiratory fitness (CRF)…
Read More
BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the confirmatory Phase 3 trial of its autologous CardiAMP cell therapy product candidate for patients with ischemic heart failure of reduced ejection fraction (HFrEF) has commenced enrollment in the United States
July 25, 2024
Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure
July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of…
Read More
In a study conducted by Brigham & Women’s Hospital, Nanox.AI-Based Analysis helps Reveal Coronary Artery Calcium in over 50% of IMID Patients; Lead author Brittany Weber, MD, PhD, declared as ‘Young Investigator Awards’ Winner
July 25, 2024
Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024
July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (…
Read More
NeuSight PET-CT 3D 64 slice scanner
July 25, 2024
Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT
July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT…
Read More
Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF) allowed their hearts to utilize more ketones and produce more energy, according to preliminary research presented by study author Qiuyu (Violet) Sun, B.Sc., a Ph.D. candidate at the University of Alberta in Canada, during an American Heart Association meeting in Chicago this week.
July 24, 2024
Increasing Cardiac Ketones May Help Heart Failure, per Mouse Study Presented at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024
>July 24, 2024 — Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (…
Read More
FibriCheck is now the only FDA-cleared smartphone application for heart rhythm monitoring with ECG equivalence in the U.S.
July 24, 2024
FibriCheck Enters US Market with FDA Clearance
July 24, 2024 — After a rigorous investigation procedure by the Food and Drug Administration, FibriCheck is now FDA-…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now